Related Experiment Video
Updated: Mar 14, 2026

Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement
Published on: July 29, 2013
Assessing the robustness of AI lesion risk scores at different exposure settings using an anthropomorphic breast
L Alström1,2, A Bjerkén1,2, V Dahlblom3,4
1Medical Radiation Physics, Department of Translational Medicine, Lund University, Malmö 205 02, Sweden.
Abstract:
To assess the robustness of risk scores provided by an artificial intelligence (AI) system for digital mammography (DM), when varying the exposure conditions. An anthropomorphic breast phantom containing a lesion, was imaged with DM at different tube voltages (kV), tube loadings (mAs), and anode/filter combinations (W/Rh, Mo/Mo, and Mo/Rh). The organ doses were extracted from the DICOM header and used as a substitute for average glandular dose. The images were analyzed with an AI system, which provided a lesion risk score which translates to suspicion for malignancy. Correlations between the lesion risk score and the exposure conditions were investigated. In most imaging conditions, weak to moderately strong positive associations between lesion risk scores and kV and mAs, respectively, were reported (varying by anode/filter combinations). When organ dose increased the AI risk scores plateaued, and further increase did not increase the lesion risk score. For typical clinical settings (W/Rh, 27 kV and 71 mAs) the range of lesion risk scores was 33-56 (mean: 42, SD: 9). Greatest reported variability (range: 36-63, mean: 51, SD: 12) was found at 27 kV and 36 mAs (using W/Rh). Images of suboptimal quality may result in inaccurate AI system performance. The unexpectedly large intra-group variability of AI risk scores should be further investigated.
More Related Videos
11:05Tissue-simulating Phantoms for Assessing Potential Near-infrared Fluorescence Imaging Applications in Breast Cancer Surgery
Published on: September 19, 2014
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020